Cold Chain Market for Pharmaceuticals: Distribution by Type of Primary Packaging, Type of Secondary Packaging, Type of Usability and Key Geographical Regions: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)

Description

The global cold chain market is valued at USD 6.2 billion in 2023 growing at a CAGR of 3.7% during the forecast period 2023-2035.

The cold chain represents a sophisticated system of precisely coordinated steps and equipment designed for the storage and transportation of temperature-sensitive materials. It relies on both active and passive thermal packaging solutions, encompassing cold chain shippers, insulated containers, refrigerants, and monitoring devices like data loggers. Widely applied in food, dairy, chemical, and pharmaceutical sectors, its primary goal is to extend the shelf life of perishable items such as fresh produce, vaccines, and pharmaceuticals, safeguarding their quality and efficacy. Notably, the pharmaceutical cold chain caters to the stringent temperature requirements of various pharmaceutical products, including biologics, COVID vaccines, and organ transplants, ensuring their integrity and viability. Recent advancements in cold chain monitoring, particularly the emergence of temperature sensors and real-time tracking devices, have significantly enhanced the efficiency of this process by enabling continuous monitoring during shipment.

Nevertheless, challenges persist, especially concerning packaging and temperature control during pharmaceutical storage and transportation. Inadequate packaging and temperature control contribute to a substantial percentage of drugs losing their effectiveness in some regions. Unforeseen issues like equipment failures or exposure to excessive heat can disrupt the cold chain, posing risks of damage or contamination. To address these challenges, industry stakeholders are actively pursuing hybrid solutions. These innovative approaches integrate temperature data loggers into cold chain containers, enhancing visibility and enabling more efficient tracking of pharmaceutical shipments. This integration stands as a promising alternative to conventional packaging solutions. Considering the ongoing advancements and the robust growth trajectory of the pharmaceutical cold chain market, driven by continuous industry efforts, substantial expansion is anticipated in the forecasted period.

Key Market Segments

Type of Primary Packaging

Vials
Ampoules
Pre-filled Syringes
Bags

Type of Secondary Packaging

Cold Boxes
Vaccine Carriers
Insulated Containers

Type of Usability

Reusable
Single use

Key Geographical Regions:

North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
Rest of the World

Research Coverage:

The report studies the cold chain market for pharmaceuticals based on type of primary packaging, type of secondary packaging, type of usability and key geographical regions
The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
The report assesses the potential advantages and obstacles within the market for those involved and offers information on the competitive environment for top players in the market.
The report forecasts the revenue of market segments with respect to six major regions
Detailed insights into the research approach adopted, encompassing methodologies, assumptions, and quality control measures employed to ensure precision and reliability of findings.
Historical trends, currency fluctuations, foreign exchange impacts, and measurements related to recession and inflation affecting the overall cold chain market for pharmaceuticals.
A high-level overview of current status and probable future evolution of the cold chain market in pharmaceuticals over the mid-to-long term.
Explaining cold chain packaging, its historical timeline, various packaging solutions, applications in the pharmaceutical industry, existing challenges, and future perspectives.
Comprehensive evaluation of 72 cold chain container/shipper providers based on parameters like establishment year, company size, headquarters location, product types, materials used, temperature storage, and services offered.
Detailed analysis of 70 data logger providers considering establishment year, company size, headquarters location, product types, data transmission modes, monitored parameters, and temperature ranges.
Comparison of key focus areas among cold chain container/shipper providers in North America, Europe, and Asia-Pacific, facilitating stakeholders to identify competitive advantages.
Detailed profiles of key cold chain container/shipper providers, highlighting company overview, product and service portfolios, recent developments, future outlook, and profiles of leading hybrid solution providers.
Examination of partnerships, collaborations, mergers, and acquisitions among stakeholders since 2019, including details on partnership types, applications, geography, and active players in the industry.
In-depth exploration of patents filed or granted since 2019, covering types, publication and application years, organizations, jurisdictions, focus areas, leading industry players, benchmarking, and valuation analysis.
Detailed discussion on regulatory guidelines issued by international and regional authorities, providing recommendations for different stages of the cold chain process along with a comparative analysis of regulatory bodies.
Examination of emerging trends, growth opportunities, technological advancements (AI, AR, IoT, etc.), real-time monitoring, integration methods, associated benefits, and cost efficiencies in the cold chain pharmaceutical industry.
Analysis of factors influencing the growth of the cold chain market for pharmaceuticals, including drivers, restraints, opportunities, and challenges.

Key Benefits of Buying this Report:

The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the cold chain market for pharmaceuticals, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Key Market Companies

Cold Chain Technologies
Cryopak
CSafe

EMBALL'ISO

Intelsius
Nordic Cold Chain Solutions
Peli BioThermal

SEE

SOFRIGAM

Sonoco Thermosafe
Tempack

Product Code: RA100459

1. PREFACE

1.1. Cold Chain Market for Pharmaceuticals
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY

2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
- 2.7.1. Demographics
- 2.7.2. Economic Factors
- 2.7.3. Government Regulations
- 2.7.4. Supply Chain
- 2.7.5. COVID Impact / Related Factors
- 2.7.6. Market Access
- 2.7.7. Healthcare Policies
- 2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview
3.2. Market Dynamics
- 3.2.1. Time Period
  - 3.2.1.1. Historical Trends
  - 3.2.1.2. Current and Forecasted Estimates
- 3.2.2. Currency Coverage
  - 3.2.2.1. Overview of Major Currencies Affecting the Market
  - 3.2.2.2. Impact of Currency Fluctuations on the Industry
- 3.2.3. Foreign Exchange Impact
  - 3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
  - 3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
- 3.2.4. Recession
  - 3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
  - 3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
- 3.2.5. Inflation
  - 3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
  - 3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview
5.2. Introduction to Cold Chain Packaging
5.3. Historical Timeline of Cold Chain
5.4. Cold Chain Solutions for Pharmaceutical Industry
- 5.4.1. Cold Chain Packaging Solutions: Containers and Shippers
  - 5.4.1.1. Active Cold Chain Packaging Solutions
  - 5.4.1.2. Passive Cold Chain Packaging Solutions
  - 5.4.1.3. Insulated Cold Chain Packaging Solutions
- 5.4.2. Cold Chain Monitoring Solutions: Data Loggers
  - 5.4.2.1. Data Loggers
  - 5.4.2.2. Indicators
5.5. Applications of Cold Chain in Pharmaceutical Industry
5.6. Current Challenges and Future Perspectives

6. OVERALL MARKET LANDSCAPE: COLD CHAIN CONTAINER / SHIPPER PROVIDERS

6.1. Chapter Overview
6.2. Cold Chain Container / Shipper Providers: Overall Market Landscape
- 6.2.1. Analysis by Year of Establishment
- 6.2.2. Analysis by Company Size
- 6.2.3. Analysis by Location of Headquarters (Region)
- 6.2.4. Analysis by Location of Headquarters (Country)
- 6.2.5. Analysis by Type of Cold Chain Solution
- 6.2.6. Analysis by Type of Product Offered
- 6.2.7. Analysis by Type of Product Material
- 6.2.8. Analysis by Type of Product Packaged
- 6.2.9. Analysis by Storage Temperature
- 6.2.10. Analysis by Type of Service Offered
- 6.2.11. Analysis by Company Size and Type of Service Offered

7. OVERALL MARKET LANDSCAPE: DATA LOGGER PROVIDERS

7.1. Chapter Overview
7.2. Data Logger Providers: Overall Market Landscape
7.3. Analysis by Year of Establishment
7.4. Analysis by Company Size
7.5. Analysis by Location of Headquarters (Region)
7.6. Analysis by Location of Headquarters (Country)
7.7. Analysis by Type of Product Offered
7.8. Analysis by Mode of Data Transmission
7.9. Analysis by Type of Data Captured
7.10. Analysis by Type of Pharmaceutical Monitored
7.11. Analysis by Temperature Range
7.12. Analysis by Type of Product Offered and Mode of Data Transmission
7.13. Analysis by Type of Product Offered and Type of Data Captured

8. COMPETITIVE BENCHMARKING

8.1. Chapter Overview
8.2. Assumptions and Methodology
8.3. Competitive Benchmarking of Cold Chain Container / Shipper Providers
- 8.3.1. Competitive Benchmarking: Players based in North America (Peer Group I)
- 8.3.2. Competitive Benchmarking: Players based in Europe (Peer Group II)
- 8.3.3. Competitive Benchmarking: Large Players based in Asia-Pacific and RoW (Peer Group III)
8.4. Concluding Remarks

9. COMPANY PROFILES

9.1. Chapter Overview
9.2. Cold Chain Technologies
- 9.2.1. Company Overview
- 9.2.2. Product Portfolio
- 9.2.3. Service Portfolio
- 9.2.4. Recent Developments and Future Outlook
9.3. Cryopak
- 9.3.1. Company Overview
- 9.3.2. Product Portfolio
- 9.3.3. Service Portfolio
- 9.3.4. Recent Developments and Future Outlook
9.4. CSafe
- 9.4.1. Company Overview
- 9.4.2. Product Portfolio
- 9.4.3. Service Portfolio
- 9.4.4. Recent Developments and Future Outlook
9.5. EMBALL'ISO
- 9.5.1. Company Overview
- 9.5.2. Product Portfolio
- 9.5.3. Service Portfolio
- 9.5.4. Recent Developments and Future Outlook
9.6. Intelsius
- 9.6.1. Company Overview
- 9.6.2. Product Portfolio
- 9.6.3. Service Portfolio
- 9.6.4. Recent Developments and Future Outlook
9.7. Nordic Cold Chain Solutions
- 9.7.1. Company Overview
- 9.7.2. Product Portfolio
- 9.7.3. Service Portfolio
- 9.7.4. Recent Developments and Future Outlook
9.8. Peli BioThermal
- 9.8.1. Company Overview
- 9.8.2. Product Portfolio
- 9.8.3. Service Portfolio
- 9.8.4. Recent Developments and Future Outlook
9.9. SEE
- 9.9.1. Company Overview
- 9.9.2. Product Portfolio
- 9.9.3. Service Portfolio
- 9.9.4. Recent Developments and Future Outlook
9.10. SOFRIGAM
- 9.10.1. Company Overview
- 9.10.2. Product Portfolio
- 9.10.3. Service Portfolio
- 9.10.4. Recent Developments and Future Outlook
9.11. Sonoco Thermosafe
- 9.11.1. Company Overview
- 9.11.2. Product Portfolio
- 9.11.3. Service Portfolio
- 9.11.4. Recent Developments and Future Outlook
9.12. Tempack
- 9.12.1. Company Overview
- 9.12.2. Product Portfolio
- 9.12.3. Service Portfolio
- 9.12.4. Recent Developments and Future Outlook
9.13. Other Leading Players
- 9.13.1. Almac
- 9.13.2. B Medical Systems
- 9.13.3. BioLife Solutions
- 9.13.4. CRS Mobile Cold Storage
- 9.13.5. Desert Valley Tech
- 9.13.6. Dubai Instruments
- 9.13.7. Envirotainer
- 9.13.8. Global Cold Chain Solutions (Headquartered in Australia)
- 9.13.9. Global Cold Chain Solutions (Headquartered in Singapore)
- 9.13.10. Klinge
- 9.13.11. Krautz-temax
- 9.13.12. Meds2go
- 9.13.13. phasetwo
- 9.13.14. Polar Tech Industries
- 9.13.15. Skycell
- 9.13.16. UPS Healthcare

10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview
10.2. Partnership Models
10.3. Cold Chain for Pharmaceuticals: Partnerships and Collaborations
- 10.3.1. Analysis by Year of Partnership
- 10.3.2. Analysis by Type of Partnership
- 10.3.3. Analysis by Year and Type of Partnership
- 10.3.4. Analysis by Application Area
- 10.3.5. Analysis by Type of Product / Technology
- 10.3.6. Analysis by Geography
  - 10.3.6.1. Local and International Agreements
  - 10.3.6.2. Intercontinental and Intracontinental Agreements
- 10.3.7 Most Active Players: Analysis by Number of Partnerships
10.4. Cold Chain for Pharmaceuticals: Acquisitions
- 10.4.1. Analysis by Year of Acquisition
- 10.4.2. Analysis by Type of Acquisition
- 10.4.2. Analysis by Year and Type of Acquisition
- 10.4.3. Analysis by Application Area
- 10.4.4. Analysis by Type of Product / Technology
- 10.4.5. Analysis by Geography
  - 10.4.5.1. Local and International Agreements
  - 10.4.5.2. Intercontinental and Intracontinental Agreements
- 10.4.6. Ownership Change Matrix
- 10.4.7. Analysis by Key Value Drivers

11. PATENT ANALYSIS

11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Cold Chain for Pharmaceuticals: Patent Analysis
- 11.3.1. Analysis by Type of Patent
- 11.3.2. Analysis by Publication Year
- 11.3.3. Analysis by Type of Patent and Publication Year
- 11.3.4. Analysis by Application Year
- 11.3.5. Analysis by Type of Organization
- 11.3.6. Analysis by Patent Jurisdiction
- 11.3.7. Analysis by CPC Symbols
- 11.3.8. Analysis by Emerging Focus Area
- 11.3.9. Leading Industry Players: Analysis by Number of Patents
11.4. Cold Chain for Pharmaceuticals: Patent Benchmarking Analysis
- 11.4.1. Analysis by Patent Characteristics
  - 11.4.1.1. Cold Chain Technologies and Ember LifeSciences
  - 11.4.1.2. Other Leading Patent Assignees
11.5. Patent Valuation Analysis

12. REGULATORY RECOMMENDATIONS AND GUIDELINES

12.1. Chapter Overview
12.2. Regulatory Guidelines Issued by International Authorities
- 12.2.1. World Health Organization (WHO)
- 12.2.2. International Air Transport Association (IATA)
- 12.2.3. International Safe Transit Association (ISTA)
12.3. Regulatory Guidelines Issued by Regional Authorities
- 12.3.1. Regulatory Guidelines for Cold Chain Management in the US
  - 12.3.1.1. United States Food and Drug Administration (USFDA)
- 12.3.2. United States Pharmacopeia (USP)
- 12.3.3. Regulatory Guidelines for Cold Chain Management in Canada
  - 12.3.3.1. Health Canada
- 12.3.4. Regulatory Guidelines for Cold Chain Management in Europe
  - 12.3.4.1. European Medicine Agency
12.4. Recommendations for Different Steps of Cold Chain
12.5. Comparative Analysis of Regulatory Authorities

13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES

13.1. Chapter Overview
13.2. Connected Cold Chain: Key Tools and Technologies
- 13.2.1. Artificial Intelligence
- 13.2.2. Augmented Reality
- 13.2.3. Automation and Robotics
- 13.2.4. Big Data Analytics
- 13.2.5. Block Chain Technology
- 13.2.6. Cloud Computing
- 13.2.7. Internet of Things
- 13.2.8. Radio Frequency Identification (RFID) Tags
13.3. Connected Cold Chain: Future Growth Opportunities
13.4. Real-Time Monitoring: An Application of Connected Cold Chain Solutions
- 13.4.1 Methods for Integration of Real-Time Monitoring in Cold Chain
  - 13.4.1.1. RFID Based Real-Time Monitoring
  - 13.4.1.2. Blockchain And IoT Based Real-Time Monitoring
- 13.4.2. Growth Opportunities for Real-Time Monitoring in Connected Cold Chain
- 13.4.3. Cost Benefits of Real-Time Monitoring in Cold Chain

14. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

14.1. Chapter Overview
14.2. Market Drivers
14.3. Market Restraints
14.4. Market Opportunities
14.5. Market Challenges
14.6. Conclusion

15. COLD CHAIN MARKET FOR PHARMACEUTICALS

15.1. Chapter Overview
15.2. Assumptions and Methodology
15.3. Global Cold Chain Market for Pharmaceuticals, Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
- 15.3.1. Scenario Analysis
15.4. Key Market Segmentations
15.5. Dynamic Dashboard

16. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF PRIMARY PACKAGING

16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Vials: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.4. Ampoules: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.5. Pre-filled Syringes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.6. Bags: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
16.7. Data Triangulation
- 16.7.1. Insights from Primary Research
- 16.7.2. Insights from Secondary Research
- 16.7.3. Insights from In-house Repository

17. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF SECONDARY PACKAGING

17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Cold Boxes: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.4. Vaccine Carriers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.5. Insulated Containers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
17.6. Data Triangulation
- 17.6.1. Insights from Primary Research
- 17.6.2. Insights from Secondary Research
- 17.7.3. Insights from In-house Repository

18. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY TYPE OF USABILITY

18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Reusable Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
18.4. Single-use Containers / Shippers: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)

19. COLD CHAIN MARKET FOR PHARMACEUTICALS, BY KEY GEOGRAPHICAL REGIONS

19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.4. Europe: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.5. Asia-Pacific: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.6. Middle East and North America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.7. Latin America: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035
19.8. Rest of the World: Historical Trends (2019-2022) and Forecasted Estimates (2023-2035)
19.9. Data Triangulation
- 19.9.1. Insights from Primary Research
- 19.9.2. Insights from Secondary Research
- 19.9.3. Insights from In-house Repository

20. CONCLUSION

21. EXECUTIVE INSIGHTS

21.1. Chapter Overview
21.2. EMBALL'ISO
- 21.2.1. Company Snapshot
- 21.2.2. Interview Transcript
21.3. Tower Cold Chain
- 21.3.1. Company Snapshot
- 21.3.2. Interview Transcript